pharmaphorum January 19, 2026
Sun Pharma has downplayed a rumour that it is in talks to acquire women’s health specialist Organon, after a report suggested a $10 billion offer was being discussed.
In a statement to the stock exchange in India, the Mumbai-headquartered group said that an article that appeared in The Economic Times today is “speculative in nature and there is no material event or information that requires disclosure.”
It added: “We adhere to the highest standards of governance and disclosures and will keep the stock exchanges informed of any material events.”
The report – which cited people familiar with the development – suggested Sun Pharma wants to acquire Organon to boost its presence in the US market and tap into its position...
Today's Sponsors
Today's Sponsor